No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
3% sd-101 dermal cream |
- |
- |
- |
- |
1件: 36 |
2 |
6% sd-101 dermal cream |
- |
- |
- |
- |
1件: 36 |
3 |
Abh001 |
- |
- |
- |
- |
1件: 36 |
4 |
Ac-203 |
- |
- |
- |
- |
1件: 36 |
5 |
Allantoin |
Allantoin |
D00121 |
- |
- |
1件: 36 |
6 |
Allo-apz2-eb |
- |
- |
- |
- |
1件: 36 |
7 |
Allo-asc-dfu |
- |
- |
- |
- |
1件: 36 |
8 |
Allogeneic mesenchymal stromal cells |
- |
- |
- |
- |
1件: 36 |
9 |
Allogeneic skin-derived abcb5-positive mesenchymal stem cells |
- |
- |
- |
- |
1件: 36 |
10 |
Alwextin cream |
- |
- |
- |
- |
1件: 36 |
11 |
Anti-thymocyte globulin |
- |
- |
- |
- |
18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 |
12 |
Birch bark extract |
- |
- |
- |
- |
1件: 36 |
13 |
Blood test |
- |
- |
- |
- |
5件: 36, 86, 113, 162, 299 |
14 |
Botulinic toxin |
- |
- |
- |
- |
1件: 36 |
15 |
Broccoli |
Broccoli |
- |
- |
- |
2件: 36, 299 |
16 |
Busilvex |
- |
- |
- |
- |
4件: 19, 36, 60, 65 |
17 |
Busulfan |
Busulfan |
D00248 |
- |
- |
13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
18 |
Calcipotriol |
Calcipotriol |
D01125 |
1件: VDR |
4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
1件: 36 |
19 |
Ccp-020 |
- |
- |
- |
- |
1件: 36 |
20 |
Ccp-020 (diacerein 1% ointment) |
Diacerein |
D07270 |
- |
- |
1件: 36 |
21 |
Cell transplantation |
- |
- |
- |
- |
1件: 36 |
22 |
Cultured allogeneic fibroblasts |
- |
- |
- |
- |
1件: 36 |
23 |
Cx501 |
Cx501 |
- |
- |
- |
1件: 36 |
24 |
Cyclophosphamide |
Cyclophosphamide |
D00287, D07760 |
- |
- |
43件: 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 61, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 |
25 |
Cyclosporine |
Ciclosporin |
D00184 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
33件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 |
26 |
Cyclosporine a |
Ciclosporin |
D00184 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
8件: 19, 20, 36, 49, 53, 58, 60, 234 |
27 |
Células madre mesenquimales haploidénticas derivadas de médula ósea |
- |
- |
- |
- |
1件: 36 |
28 |
Diacerein |
Diacerein |
D07270 |
- |
- |
2件: 36, 46 |
29 |
Diacerein 1% ointment |
Diacerein |
D07270 |
- |
- |
1件: 36 |
30 |
Diacerein 1% ointment topical formulation |
Diacerein |
D07270 |
- |
- |
1件: 36 |
31 |
Diacerin cream |
- |
- |
- |
- |
1件: 36 |
32 |
Donor mesenchymal stem cell infusions |
- |
- |
- |
- |
1件: 36 |
33 |
Dysport |
Botulinum toxin type a |
D00783 |
1件: SNAP25 |
2件: Insulin secretion, Synaptic vesicle cycle |
2件: 13, 36 |
34 |
Eb-101 |
- |
- |
- |
- |
1件: 36 |
35 |
Episalvan gel |
- |
- |
- |
- |
1件: 36 |
36 |
Erythrocine |
- |
- |
- |
- |
1件: 36 |
37 |
Erythrocine oral |
- |
- |
- |
- |
1件: 36 |
38 |
Erythromycin |
Erythromycin |
D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054 |
- |
- |
5件: 6, 36, 164, 228, 291 |
39 |
Erythromycine |
- |
- |
- |
- |
1件: 36 |
40 |
Fibroblasts |
- |
- |
- |
- |
1件: 36 |
41 |
Fludarabine |
Fludarabine |
D01907, D07966 |
1件: RRM1 |
5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
42 |
Fludarabine phosphate |
Fludarabine |
D01907, D07966 |
1件: RRM1 |
5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 |
43 |
Gcsf |
Filgrastim |
D03235 |
1件: CSF3R |
5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
3件: 36, 65, 284 |
44 |
Gene-modified autologous fibroblasts |
- |
- |
- |
- |
1件: 36 |
45 |
Gentamicin |
Gentamicin |
D01063, D08013 |
- |
- |
3件: 36, 113, 299 |
46 |
Gentamicin sulfate |
Gentamicin |
D01063, D08013 |
- |
- |
1件: 36 |
47 |
Gentamicin sulfate, injectable |
Gentamicin |
D01063, D08013 |
- |
- |
1件: 36 |
48 |
Granulocyte colony stimulating factor |
Filgrastim |
D03235 |
1件: CSF3R |
5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
3件: 2, 36, 85 |
49 |
Granulocyte colony stimulating factor (gcsf) |
Filgrastim |
D03235 |
1件: CSF3R |
5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
1件: 36 |
50 |
Hologene17 |
- |
- |
- |
- |
1件: 36 |
51 |
Hologene7 |
- |
- |
- |
- |
1件: 36 |
52 |
Hp802-247 |
- |
- |
- |
- |
1件: 36 |
53 |
Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh |
- |
- |
- |
- |
1件: 36 |
54 |
Human fibroblast-derived dermal substitute, dermagraft |
- |
- |
- |
- |
1件: 36 |
55 |
Icx-rhy-013 |
- |
- |
- |
- |
1件: 36 |
56 |
Isotretinoin |
Isotretinoin |
D00348 |
2件: RARA, RARB |
8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
4件: 36, 39, 159, 160 |
57 |
Jojoba oil |
Jojoba oil |
- |
- |
- |
1件: 36 |
58 |
Jojoba oil with broccoli sprout extract |
Jojoba oil |
- |
- |
- |
1件: 36 |
59 |
Lzrse-col7a1 engineered autologous epidermal sheets |
- |
- |
- |
- |
1件: 36 |
60 |
Mesenchymal stem cells (mscs) |
- |
- |
- |
- |
3件: 13, 36, 96 |
61 |
Mesenchymal stem cells derived from bone marrow (bm-mscs) |
- |
- |
- |
- |
1件: 36 |
62 |
Mesenchymal stem cells extracted from bone marrow |
- |
- |
- |
- |
1件: 36 |
63 |
Mesenchymal stromal cells |
- |
- |
- |
- |
6件: 36, 51, 96, 97, 274, 284 |
64 |
Methoxsalen |
Methoxsalen |
D00139 |
- |
- |
3件: 36, 46, 96 |
65 |
Morphine |
Morphine |
D00842, D02271, D08233 |
1件: OPRM1 |
3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
4件: 36, 46, 70, 86 |
66 |
Morphine sulphate in intrasite gel |
Morphine |
D00842, D02271, D08233 |
1件: OPRM1 |
3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
1件: 36 |
67 |
Mycophenolate |
Mycophenolic acid |
D05096 |
2件: IMPDH1, IMPDH2 |
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
33件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
68 |
Mycophenolate mofetil |
Mycophenolate mofetil |
D00752, D05094, D05095 |
2件: IMPDH1, IMPDH2 |
3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
69 |
Normal saline |
- |
- |
- |
- |
14件: 6, 17, 22, 36, 46, 49, 60, 94, 96, 211, 226, 276, 296, 299 |
70 |
Oleogel-s10 |
- |
- |
- |
- |
1件: 36 |
71 |
On 01910.na |
- |
- |
- |
- |
1件: 36 |
72 |
Oral erythromycin |
Erythromycin |
D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054 |
- |
- |
1件: 36 |
73 |
Phosphate |
Phosphate ion |
- |
- |
- |
29件: 2, 3, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 283, 284, 285, 286, 299 |
74 |
Polyphenon e |
- |
- |
- |
- |
2件: 13, 36 |
75 |
Pregabalin |
Pregabalin |
D02716 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway |
5件: 13, 36, 46, 70, 298 |
76 |
Psorcutan-ointment |
- |
- |
- |
- |
1件: 36 |
77 |
Ptr-01 |
- |
- |
- |
- |
1件: 36 |
78 |
Qr-313 |
- |
- |
- |
- |
1件: 36 |
79 |
Qr-313 gel for topical (cutaneous) administration |
- |
- |
- |
- |
1件: 36 |
80 |
Reduced intensity transplant conditioning |
- |
- |
- |
- |
1件: 36 |
81 |
Rege pro dressing |
- |
- |
- |
- |
1件: 36 |
82 |
Rgn-137 |
- |
- |
- |
- |
1件: 36 |
83 |
Rigosertib |
Rigosertib |
D10154 |
1件: PLK1 |
4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
1件: 36 |
84 |
Rigosertib oral capsules / rigosertib oral liquid solution / rigosertib intravenous |
Rigosertib |
D10154 |
1件: PLK1 |
4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
1件: 36 |
85 |
Rituximab |
Rituximab |
D02994 |
1件: MS4A1 |
1件: Hematopoietic cell lineage |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
86 |
Ropivacaine |
Ropivacaine |
D04048, D08490 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A |
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
3件: 36, 46, 70 |
87 |
Sd-101 |
- |
- |
- |
- |
1件: 36 |
88 |
Sd-101 dermal cream (6%) |
- |
- |
- |
- |
1件: 36 |
89 |
Sd-101-6.0 cream |
- |
- |
- |
- |
1件: 36 |
90 |
Sericare |
- |
- |
- |
- |
1件: 36 |
91 |
Sericare® |
- |
- |
- |
- |
1件: 36 |
92 |
Serlopitant |
Serlopitant |
D09378 |
1件: TACR1 |
2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
1件: 36 |
93 |
Serlopitant tablet |
Serlopitant |
D09378 |
1件: TACR1 |
2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
1件: 36 |
94 |
Simplecare |
- |
- |
- |
- |
1件: 36 |
95 |
Sin lv mediated ex vivo transduced autologous fibroblasts expressing codon-optimised col7a1 |
- |
- |
- |
- |
1件: 36 |
96 |
Sirolimus |
Sirolimus |
D00753 |
1件: MTOR |
43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
30件: 13, 17, 34, 35, 36, 46, 51, 60, 62, 63, 65, 66, 67, 85, 89, 96, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
97 |
Sirolimus 2% |
Sirolimus |
D00753 |
1件: MTOR |
43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
2件: 36, 192 |
98 |
Sirolimus, 2% |
Sirolimus |
D00753 |
1件: MTOR |
43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
2件: 36, 192 |
99 |
Sulfate |
Sulfate ion |
- |
- |
- |
22件: 2, 6, 11, 13, 26, 34, 36, 46, 49, 60, 61, 64, 66, 79, 86, 96, 222, 226, 265, 296, 297, 299 |
100 |
Tacrolimus |
Tacrolimus |
D00107, D08556 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
29件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
101 |
Tc-msc |
- |
- |
- |
- |
1件: 36 |
102 |
Tetracyclin |
Tetracycline |
D00201 |
- |
- |
1件: 36 |
103 |
Thymoglobulin |
- |
- |
- |
- |
4件: 36, 51, 60, 96 |
104 |
Thymoglobuline |
- |
- |
- |
- |
4件: 13, 36, 51, 65 |
105 |
Thymosin beta 4 |
- |
- |
- |
- |
2件: 36, 53 |
106 |
Topical bercolagene telserpavec |
- |
- |
- |
- |
1件: 36 |
107 |
Topical bpm31510 3.0% cream |
- |
- |
- |
- |
1件: 36 |
108 |
Topical opiod |
- |
- |
- |
- |
1件: 36 |
109 |
Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col17a1-encoding retroviral vector |
- |
- |
- |
- |
1件: 36 |
110 |
Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector |
- |
- |
- |
- |
1件: 36 |
111 |
Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes. |
- |
- |
- |
- |
1件: 36 |
112 |
Trimethoprim |
Trimethoprim |
D00145, D06236 |
- |
- |
6件: 36, 44, 49, 60, 85, 299 |
113 |
Triterpene dry extract from birch cork |
- |
- |
- |
- |
1件: 36 |
114 |
Unavailable |
- |
- |
- |
- |
1件: 36 |
115 |
Vehicle |
- |
- |
- |
- |
4件: 6, 36, 160, 192 |
116 |
Vehicle (0% sd-101) |
- |
- |
- |
- |
1件: 36 |
117 |
Vpd-737 |
- |
- |
- |
- |
1件: 36 |
118 |
Zorblisa |
- |
- |
- |
- |
1件: 36 |